Cardinal Health (CAH) FY2015 results: revenue $102.5 billion, up 12.6% on the year
Cardinal Health Inc. (CAH) reported revenue of $102.5 billion for fiscal 2015, the year ended 30 June 2015, up 12.6% on the year before. Net income was $1.2 billion, up 4.2%, and diluted earnings per share $3.62. The figures are the company's own, from the 10-K it filed with the SEC on 13 August 2015.
Revenue
$102.5 billion
+12.6% on the year
FY2008FY2015
Operating margin
2.1%
2.1% a year earlier
FY2008FY2015
Net income
$1.2 billion
+4.2% on the year
FY2008FY2015
Diluted EPS
$3.62
+7.1% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
102,531
91,084
101,093
+12.6%
Cost of revenue
96,819
85,923
96,172
+12.7%
Gross profit
5,712
5,161
4,921
+10.7%
Gross margin
5.6%
5.7%
4.9%
Selling, general and administrative
3,240
3,028
2,875
+7.0%
Operating income
2,161
1,885
996
+14.6%
Operating margin
2.1%
2.1%
1.0%
Interest expense
141
133
123
+6.0%
Pre-tax income
1,967
1,798
888
+9.4%
Income tax
755
635
553
+18.9%
Effective tax rate
38.4%
35.3%
62.3%
Net income
1,215
1,166
334
+4.2%
Net margin
1.2%
1.3%
0.3%
Diluted EPS
$3.62
$3.38
$0.97
+7.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
2,540
2,524
1,727
+0.6%
Capital expenditure
300
249
195
+20.5%
Free cash flow
2,240
2,275
1,532
-1.5%
Free cash flow margin
2.2%
2.5%
1.5%
Cash from investing
-849
-850
-2,375
Cash from financing
60.0
-710
275
Depreciation and amortisation
451
459
397
-1.7%
Share-based compensation
110
96.0
93.0
+14.6%
Buybacks
1,036
673
450
+53.9%
Dividends paid
460
415
353
+10.8%
Dividend per share
$1.37
$1.21
$1.02
+13.2%
Diluted shares, weighted
335m
345m
344m
-2.9%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
6,256
6,401
5,975
-2.3%
Non-controlling interest
0.0
n/a
n/a
Redeemable equity
0.0
n/a
n/a
Debt
5,492
3,972
3,854
+38.3%
Other liabilities
18,394
15,660
15,990
+17.5%
Total liabilities and equity
30,142
26,033
25,819
+15.8%
Fixed assets
1,506
1,459
1,489
+3.2%
Goodwill
5,070
4,878
4,601
+3.9%
Intangible assets
948
992
973
-4.4%
Investments
193
100
n/a
+93.0%
Cash and equivalents
4,616
2,865
1,901
+61.1%
Receivables
6,523
5,380
6,304
+21.2%
Inventory
9,211
8,266
8,373
+11.4%
Other assets
2,075
2,093
2,178
-0.9%
Total assets
30,142
26,033
25,819
+15.8%
10-K for the year ended 30 June 2015, filed 13 August 2015: the filing.